Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -23,296 | -15,725 | -9,649 | N/A |
| Depreciation Amortization | 21 | 10 | 9 | N/A |
| Accounts payable and accrued liabilities | 760 | -759 | -119 | N/A |
| Other Working Capital | 204 | 1 | 97 | N/A |
| Other Operating Activity | 1,190 | 997 | 329 | 0 |
| Operating Cash Flow | $-21,121 | $-15,476 | $-9,333 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -25 | -23 | -8 | N/A |
| Other Investing Activity | -150 | -30 | 0 | 0 |
| Investing Cash Flow | $-175 | $-53 | $-8 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 97,945 | 215 | 4 | N/A |
| Other Financing Activity | -3,146 | 35,376 | 18,775 | 0 |
| Financing Cash Flow | $94,799 | $35,591 | $18,779 | $N/A |
| Beginning Cash Position | 31,753 | 11,691 | 2,253 | N/A |
| End Cash Position | 105,256 | 31,753 | 11,691 | N/A |
| Net Cash Flow | $73,503 | $20,062 | $9,438 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,121 | -15,476 | -9,333 | N/A |
| Capital Expenditure | -25 | -23 | -8 | N/A |
| Free Cash Flow | -21,146 | -15,499 | -9,341 | 0 |